Her clinical expertise is in the management of lung cancers and palliative radiotherapy. In Aug 2003, she assumed leadership of the Radiation Medicine Program (RMP) Lung Group, and has created a multi-professional team that has embarked on a program of high precision radiotherapy in lung cancer, utilizing the cutting-edge technology now available within RMP including 4 D-CT for treatment planning, PET-CT simulator for target definition and cone beam CT for image verification.

She is the local PI of the RTOG phase I/II study of stereotactic RT for T1-T3NO non-small cell lung cancers in medically inoperable patients. She is also collaborating with Dr. Richard Hill and others in assessing the effect of radiotherapy on normal tissues, particularly lung.